Janux Therapeutics, Inc. (JANX)
14.93
+0.09
(+0.61%)
USD |
NASDAQ |
Apr 06, 15:53
Janux Therapeutics SG&A Expense (TTM) : 41.77M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Bristol Myers Squibb Co. | 7.267B |
| EyePoint Plc | 51.70M |
| CorMedix, Inc. | 99.77M |
| ADMA Biologics, Inc. | 96.42M |
| Viking Therapeutics, Inc. | 48.39M |